0001104659-23-073231.txt : 20230621 0001104659-23-073231.hdr.sgml : 20230621 20230621105848 ACCESSION NUMBER: 0001104659-23-073231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230621 DATE AS OF CHANGE: 20230621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AUBERTON-HERVE ANDRE-JACQUES CENTRAL INDEX KEY: 0001730329 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54717 FILM NUMBER: 231028349 MAIL ADDRESS: STREET 1: 18 CHEMIN DE LA VIERGE NOIRE CITY: LA TRONCHE STATE: I0 ZIP: 38700 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bionik Laboratories Corp. CENTRAL INDEX KEY: 0001508381 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 271340346 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 80 COOLIDGE HILL ROAD CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 1-617-926-4800 MAIL ADDRESS: STREET 1: 80 COOLIDGE HILL ROAD CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Drywave Technologies, Inc. DATE OF NAME CHANGE: 20130814 FORMER COMPANY: FORMER CONFORMED NAME: Strategic Dental Management Corp. DATE OF NAME CHANGE: 20101220 4 1 tm2319148-4_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-13 0 0001508381 Bionik Laboratories Corp. BNKL 0001730329 AUBERTON-HERVE ANDRE-JACQUES C/O BIONIK LABORATORIES CORP. 80 COOLIDGE HILL ROAD WATERTOWN MA 02472 1 0 0 0 0 Common Stock 2023-06-13 4 C 0 186111 0.60 A 1109271 I Shares held through Star SCI Common Stock 10693 I Shares held through 4A Consulting and Engineering Common Stock 95149 D Convertible Promissory Note 0.60 2023-06-13 4 P 0 1 220000 A 2024-06-01 Common Stock, par value $0.001 per share 366667 1 I Through Star SCI Effective as of June 13, 2023, approximately $310,185 of principal and accrued interest of a convertible promissory note issued to Star SCI, an affiliate of the reporting person, converted in accordance with its terms into 186,111 shares of the Issuer's common stock The convertible promissory note (the "Note") will be convertible into common stock of the Issuer upon the following events on the following terms: (a) on June 1, 2024 without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to $0.60 per share; and (b) upon the consummation of the next equity or equity linked round of financing of the Issuer for cash proceeds (the "Qualified Financing"), without any action on the part of the reporting person, the outstanding principal and accrued and unpaid interest under the Note will be converted into shares of common stock at a conversion price equal to the lesser of (a) the issue price per share in the Qualified Financing and (b) $0.60 per share. /s/ Andre-Jacques Auberton-Herve 2023-06-20